Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome

Edinson Dante Meregildo-Rodriguez; Victor Hugo Bardales-Zuta

doi:10.53854/liim-2904-13

Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome

Edinson Dante Meregildo-Rodriguez
, Victor Hugo Bardales-Zuta

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	589-599
Number of pages	11
Journal	Infezioni in Medicina
Volume	29
Issue number	4
DOIs	https://doi.org/10.53854/liim-2904-13
State	Published - 1 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.53854/liim-2904-13

Cite this

@article{6231c65adb754d5991923fa6eacbaa5c,

title = "Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barr{\'e} syndrome",

keywords = "Disability, Guillain-Barr{\'e} syndrome, Mortality, Therapy",

author = "Meregildo-Rodriguez, \{Edinson Dante\} and Bardales-Zuta, \{Victor Hugo\}",

year = "2021",

month = jan,

day = "1",

doi = "10.53854/liim-2904-13",

language = "English",

volume = "29",

pages = "589--599",

journal = "Infezioni in Medicina",

issn = "1124-9390",

publisher = "EDIMES Edizioni Medico Scientifiche",

number = "4",

}

TY - JOUR

T1 - Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome

AU - Meregildo-Rodriguez, Edinson Dante

AU - Bardales-Zuta, Victor Hugo

PY - 2021/1/1

Y1 - 2021/1/1

KW - Disability

KW - Guillain-Barré syndrome

KW - Mortality

KW - Therapy

UR - https://www.scopus.com/pages/publications/85121274151

U2 - 10.53854/liim-2904-13

DO - 10.53854/liim-2904-13

M3 - Article

AN - SCOPUS:85121274151

SN - 1124-9390

VL - 29

SP - 589

EP - 599

JO - Infezioni in Medicina

JF - Infezioni in Medicina

IS - 4

ER -

Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this